1. Industry Overview
Course intro
()
Industry definition and purpose: Part 1
()
Industry definition and purpose: Part 2
()
Industry subsegments and clinical trial operations: Part 1
()
Industry subsegments and clinical trial operations: Part 2
()
Canonical tensions that define the industry: Part 1
()
Canonical tensions that define the industry: Part 2
()
2. Terminology
Core vocabulary and acronyms: Part 1
()
Core vocabulary and acronyms: Part 2
()
Industry frameworks and concepts: Part 1
()
Industry frameworks and concepts: Part 2
()
3. Market Landscape
Key players and market structure: Part 1
()
Key players and market structure: Part 2
()
Competitive dynamics: Part 1
()
Competitive dynamics: Part 2
()
Market risks: Part 1
()
Market risks: Part 2
()
4. Industry Value Chain and Operating Models
End-to-end pharmaceutical value chain: Part 1
()
End-to-end pharmaceutical value chain: Part 2
()
Key value-creating activities: Part 1
()
Key value-creating activities: Part 2
()
Stakeholders, profit pools, bottlenecks, and operating models: Part 1
()
Stakeholders, profit pools, bottlenecks, and operating models: Part 2
()
5. Business Models: Economic and Financial Drivers
Revenue and cost structure: Part 1
()
Revenue and cost structure- Part 2
()
Key performance indicators and analytics: Part 1
()
Key performance indicators and analytics: Part 2
()
6. Customer and Stakeholders
Customer segments and decision drivers: Part 1
()
Customer segments and decision drivers: Part 2
()
Stakeholder ecosystem and influence dynamics: Part 1
()
Stakeholder ecosystem and influence dynamics: Part 2
()
7. Regulatory and Compliance
Regulatory bodies and key legislation: Part 1
()
Regulatory bodies and key legislation: Part 2
()
Compliance requirements and global differences: Part 1
()
Compliance requirements and global differences: Part 2
()
8. Consulting Opportunity Areas
Industry fluency and client signals: Part 1
()
Industry fluency and client signals: Part 2
()
Opportunity areas and value creation: Part 1
()
Opportunity areas and value creation: Part 2
()
Conclusion
()
Ex_Files_Industry_Primer_for_Pharmaceuticals_Core_Foundations.zip
(170 KB)